Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The decrease of -synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies

Identifieur interne : 000427 ( Main/Exploration ); précédent : 000426; suivant : 000428

The decrease of -synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies

Auteurs : Katrin Beyer [Espagne] ; Montserrat Domingo-Sbat [Espagne] ; Cristina Santos [Espagne] ; Eduardo Tolosa [Espagne] ; Isidro Ferrer [Espagne] ; Aurelio Ariza [Espagne]

Source :

RBID : ISTEX:6BBF9B326D67DFDB7F8C32E63533539F3BA561DB

Abstract

Lewy body diseases include dementia with Lewy bodies and Parkinsons disease. Whereas dementia with Lewy bodies and Parkinsons disease can be distinguished as separate clinical entities, the pathological picture is very often identical. -synuclein aggregation is a key event in the pathogenesis of Lewy body diseases and -synuclein inhibits -synuclein aggregation in vitro and in vivo. Recently, -synuclein has been shown to interact directly with -synuclein, regulating its functionality and preventing its oligomerization. In this study, we analysed the expression of two -synuclein transcript variants and the main -synuclein transcript SNCA140, in frozen samples of three areas from brains of patients with (i) pure diffuse Lewy body pathology; (ii) pure Alzheimers disease pathology; (iii) diffuse Lewy body pathology and concomitant Alzheimers disease pathology and (iv) controls. Relative messenger RNA expression was determined by real-time polymerase chain reaction, expression changes were evaluated by the Ct method and messenger RNA expression data were confirmed at the protein level. A drastic diminution of -synuclein expression was observed in cortical areas of all samples that presented neuropathological features corresponding to pure diffuse Lewy body pathology and the clinical phenotype of dementia with Lewy bodies, but not in those with neuropathological features corresponding to diffuse Lewy body pathology and concomitant Alzheimers disease pathology or the clinical phenotype of Parkinsons disease with dementia. The correlation of expression data with the clinical phenotype and neuropathological diagnosis of the patients suggested the existence of a specific molecular subtype of dementia with Lewy bodies, characterized by a strong decrease of -synuclein in the frontal and temporal cortices. Furthermore, our findings provide new insights into the pathogenesis of Lewy body diseases that may be important for the understanding of molecular mechanisms involved in these complex diseases.

Url:
DOI: 10.1093/brain/awq275


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>The decrease of -synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies</title>
<author>
<name sortKey="Beyer, Katrin" sort="Beyer, Katrin" uniqKey="Beyer K" first="Katrin" last="Beyer">Katrin Beyer</name>
</author>
<author>
<name sortKey="Domingo Sbat, Montserrat" sort="Domingo Sbat, Montserrat" uniqKey="Domingo Sbat M" first="Montserrat" last="Domingo-Sbat">Montserrat Domingo-Sbat</name>
</author>
<author>
<name sortKey="Santos, Cristina" sort="Santos, Cristina" uniqKey="Santos C" first="Cristina" last="Santos">Cristina Santos</name>
</author>
<author>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
</author>
<author>
<name sortKey="Ferrer, Isidro" sort="Ferrer, Isidro" uniqKey="Ferrer I" first="Isidro" last="Ferrer">Isidro Ferrer</name>
</author>
<author>
<name sortKey="Ariza, Aurelio" sort="Ariza, Aurelio" uniqKey="Ariza A" first="Aurelio" last="Ariza">Aurelio Ariza</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6BBF9B326D67DFDB7F8C32E63533539F3BA561DB</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1093/brain/awq275</idno>
<idno type="url">https://api.istex.fr/document/6BBF9B326D67DFDB7F8C32E63533539F3BA561DB/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000394</idno>
<idno type="wicri:Area/Main/Curation">000341</idno>
<idno type="wicri:Area/Main/Exploration">000427</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">The decrease of -synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies</title>
<author>
<name sortKey="Beyer, Katrin" sort="Beyer, Katrin" uniqKey="Beyer K" first="Katrin" last="Beyer">Katrin Beyer</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>1 Servicio de Anatoma Patolgica, Hospital Universitario Germans Trias i Pujol, Universidad Autonoma de Barcelona</wicri:regionArea>
<wicri:noRegion>Universidad Autonoma de Barcelona</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>2 ICS Institute of Neuropathology, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation>
<wicri:noCountry code="no comma">E-mail: katrinbeyer@hotmail.com</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Domingo Sbat, Montserrat" sort="Domingo Sbat, Montserrat" uniqKey="Domingo Sbat M" first="Montserrat" last="Domingo-Sbat">Montserrat Domingo-Sbat</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>1 Servicio de Anatoma Patolgica, Hospital Universitario Germans Trias i Pujol, Universidad Autonoma de Barcelona</wicri:regionArea>
<wicri:noRegion>Universidad Autonoma de Barcelona</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Santos, Cristina" sort="Santos, Cristina" uniqKey="Santos C" first="Cristina" last="Santos">Cristina Santos</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>3 Unitat d'Antropologia Biologica, Departament de Biologia Animal, Biologia Vegetal i Ecologia, Universitat Autonoma de Barcelona</wicri:regionArea>
<wicri:noRegion>Universitat Autonoma de Barcelona</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>4 Servicio de Neurologa, Centro de Investigacin en Red de Enfermedades Neurodegenerativas (CIBERNED), Hospital Clnic, Universidad de Barcelona</wicri:regionArea>
<wicri:noRegion>Universidad de Barcelona</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ferrer, Isidro" sort="Ferrer, Isidro" uniqKey="Ferrer I" first="Isidro" last="Ferrer">Isidro Ferrer</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>2 ICS Institute of Neuropathology, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ariza, Aurelio" sort="Ariza, Aurelio" uniqKey="Ariza A" first="Aurelio" last="Ariza">Aurelio Ariza</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>1 Servicio de Anatoma Patolgica, Hospital Universitario Germans Trias i Pujol, Universidad Autonoma de Barcelona</wicri:regionArea>
<wicri:noRegion>Universidad Autonoma de Barcelona</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>2 ICS Institute of Neuropathology, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Brain</title>
<idno type="ISSN">0006-8950</idno>
<idno type="eISSN">1460-2156</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date type="published" when="2010-12">2010-12</date>
<biblScope unit="volume">133</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="3724">3724</biblScope>
<biblScope unit="page" to="3733">3733</biblScope>
</imprint>
<idno type="ISSN">0006-8950</idno>
</series>
<idno type="istex">6BBF9B326D67DFDB7F8C32E63533539F3BA561DB</idno>
<idno type="DOI">10.1093/brain/awq275</idno>
<idno type="ArticleID">awq275</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0006-8950</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Lewy body diseases include dementia with Lewy bodies and Parkinsons disease. Whereas dementia with Lewy bodies and Parkinsons disease can be distinguished as separate clinical entities, the pathological picture is very often identical. -synuclein aggregation is a key event in the pathogenesis of Lewy body diseases and -synuclein inhibits -synuclein aggregation in vitro and in vivo. Recently, -synuclein has been shown to interact directly with -synuclein, regulating its functionality and preventing its oligomerization. In this study, we analysed the expression of two -synuclein transcript variants and the main -synuclein transcript SNCA140, in frozen samples of three areas from brains of patients with (i) pure diffuse Lewy body pathology; (ii) pure Alzheimers disease pathology; (iii) diffuse Lewy body pathology and concomitant Alzheimers disease pathology and (iv) controls. Relative messenger RNA expression was determined by real-time polymerase chain reaction, expression changes were evaluated by the Ct method and messenger RNA expression data were confirmed at the protein level. A drastic diminution of -synuclein expression was observed in cortical areas of all samples that presented neuropathological features corresponding to pure diffuse Lewy body pathology and the clinical phenotype of dementia with Lewy bodies, but not in those with neuropathological features corresponding to diffuse Lewy body pathology and concomitant Alzheimers disease pathology or the clinical phenotype of Parkinsons disease with dementia. The correlation of expression data with the clinical phenotype and neuropathological diagnosis of the patients suggested the existence of a specific molecular subtype of dementia with Lewy bodies, characterized by a strong decrease of -synuclein in the frontal and temporal cortices. Furthermore, our findings provide new insights into the pathogenesis of Lewy body diseases that may be important for the understanding of molecular mechanisms involved in these complex diseases.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Espagne</li>
</country>
<region>
<li>Catalogne</li>
</region>
<settlement>
<li>Barcelone</li>
</settlement>
</list>
<tree>
<country name="Espagne">
<noRegion>
<name sortKey="Beyer, Katrin" sort="Beyer, Katrin" uniqKey="Beyer K" first="Katrin" last="Beyer">Katrin Beyer</name>
</noRegion>
<name sortKey="Ariza, Aurelio" sort="Ariza, Aurelio" uniqKey="Ariza A" first="Aurelio" last="Ariza">Aurelio Ariza</name>
<name sortKey="Ariza, Aurelio" sort="Ariza, Aurelio" uniqKey="Ariza A" first="Aurelio" last="Ariza">Aurelio Ariza</name>
<name sortKey="Beyer, Katrin" sort="Beyer, Katrin" uniqKey="Beyer K" first="Katrin" last="Beyer">Katrin Beyer</name>
<name sortKey="Domingo Sbat, Montserrat" sort="Domingo Sbat, Montserrat" uniqKey="Domingo Sbat M" first="Montserrat" last="Domingo-Sbat">Montserrat Domingo-Sbat</name>
<name sortKey="Ferrer, Isidro" sort="Ferrer, Isidro" uniqKey="Ferrer I" first="Isidro" last="Ferrer">Isidro Ferrer</name>
<name sortKey="Santos, Cristina" sort="Santos, Cristina" uniqKey="Santos C" first="Cristina" last="Santos">Cristina Santos</name>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000427 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000427 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:6BBF9B326D67DFDB7F8C32E63533539F3BA561DB
   |texte=   The decrease of -synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024